December 2017

Table of Contents


Cover Story

PBPK Modeling and Simulation: Yesterday's Scientific Endeavor is Today's Regulatory Necessity

By Amin Rostami-Hodjegan, Pharm.D., Ph.D., Adam Darwich, Ph.D., and Ellen Leinfuss
PBPK modeling and simulation has value throughout the drug development life cycle. 

Member Spotlight

Advancing the Course of PK/PD Modeling

Diane Mould, Ph.D.
Throughout her career, Diane Mould has both advanced and spread the word on computer modeling.

AAPS eLearning

FDA and EMA Issue Guidelines for PBPK Modeling

An AAPS webinar discusses regulations in the U.S. and Europe. 

President's Report

Looking back on 2017

Pharmaceutical Science Update 

U.S. Regulatory News

Regulatory  Developments


AAPS announces the 2018 Scientific Programming Committee

AAPS Publications

Embracing a New Digital Publishing  Model

AAPS Career Success

The Art and Science of Managing Up


A call for Executive Council nominations

Did You Know?

AAPS Meets with CFDA

AAPS Foundation

Meet Akshay Jain

Student Chapter Focus

2017 Student Chapter winners